Advertisement

Brinks Hofer Gilson & Lione Company Profile

04:13 EDT 22nd May 2013 | BioPortfolio

Brinks Hofer Gilson & Lione was founded in 1917 as the two-man patent law firm of Wilkinson & Huxley. Today Brinks has approximately 150 attorneys, supported by a full complement of scientific advisors, patent agents and paralegals. Our headquarters are atop Chicago's preeminent NBC Tower.
We litigate, counsel and prosecute in patent, trademark, copyright, trade secret, unfair competition, Internet and related areas of law. We routinely handle assignments in fields as diverse as electrical, chemical, mechanical, biotechnology, pharmaceutical, nanotechnology and computer technology, as well as in trademarks or brand names for a wide variety of products and services.

Brinks also takes civic pride in providing pro bono legal services to those unable to pay in matters involving eviction, immigration, asylum and criminal matters, as well as non-profits in their intellectual property law matters.

Historical
With nearly 90 years of practice experience, the firm has become rich in the history and development of intellectual property law and in the professional associations that serve it. Its members have handled landmark cases before the United States Supreme Court and the regional Courts of Appeals and have held leadership positions in all the major bar and intellectual property law associations.

Founder George Wilkinson argued and won the case in which Justice Frankfurter introduced the term "commercial magnetism" (the quality that entitles a symbol to protection) into the lexicon of trademark law. In 1930, founder Henry Huxley not only handled an active legal practice, but also taught a course in patent law at Northwestern University Law School. Both Wilkinson and Huxley rose to prominence in the American Bar Association's Patent, Trademark and Copyright section

Location

NBC Tower455 N. Cityfront Plaza Drive
Suite 3600
Chicago
Illinois
60611-5599
United States of America

Contact

Phone: (312) 321-4200
Fax: (312) 321-4299
Email: jlong@usebrinks.com


News Articles [ 8 Associated News Articles listed on BioPortfolio]

Brinks Updates Finalists in 4th Annual Brinks Innovation Competition

CHICAGO, Aug. 27, 2012 (GLOBE NEWSWIRE) -- Brinks Hofer Gilson & Lione today announced the five finalists in the 4th Annual Brinks Innovation Competition: Arid Technologies, based in Wheaton, Ill...

Detroit's SurClean Wins 4th Annual Brinks Innovation Competition

CHICAGO, Sept. 13, 2012 (GLOBE NEWSWIRE) -- Intellectual property law firm Brinks Hofer Gilson & Lione today announced that Detroit-based SurClean, a start-up that produces laser tools for removi...

Intellectual Property Law Firm Brinks to Open Detroit Office

CHICAGO, Nov. 14, 2012 (GLOBE NEWSWIRE) -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the U.S., will open a new Detroit office next month, in the same buil...

Brinks Attorney Kelly Burris Testifies Against H.R. 3889, PARTS Act

ANN ARBOR, Mich., Aug. 6, 2012 (GLOBE NEWSWIRE) -- Kelly K. Burris, a shareholder in the Ann Arbor office of Brinks Hofer Gilson & Lione, testified as an expert witness at a hearing of the House...

Gilson – closer to you

Gilson provides full sales, service and support on all of its products from a new UK operation

Brazilian court bans anti-Islam film from YouTube

A judge in Brazil has ordered YouTube to remove clips of the movie that has touched off deadly protests across the Muslim world, the court said in a statement.Judge Gilson Delgado Miranda gave the vi...

Pathway Determined For Origin Of Most Common Form Of Brain And Spinal Cord Tumor

Johns Hopkins researchers say they have discovered one of the most important cellular mechanisms driving the growth and progression of meningioma, the most common form of brain and spinal cord tumor....

Oncolytics Biotech, Inc.: An Intro To These Next Few Crucial Weeks

ByMichelle Gilson: Oncolytics Biotech, Inc. (ONCY) Product: Reolysin and 360 patents worldwide (including methods for oncolytic viral administration) Stock Price: $3.87 Net loss for 2012 expe...

Drugs and Medications [0 Results]

None

PubMed Articles [ 11 Associated PubMed Articles listed on BioPortfolio]

Reply to Brinks and Rathmann: Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study.

Targeted therapies on the horizon for malignant glioma.

The stoichiometry of single nanoparticles of copper zinc tin selenide.

Cu(2)ZnSnSe(4) nanoparticles have high potential to be used as ink for printable solar cells. Using transmission electron microscopy we show that these nanoparticles exhibit a broad range of chemical...

Molecular markers in gliomas: impact for the clinician.

Over the last decade, understanding of glioma on a molecular level has greatly expanded. However, optimal incorporation of molecular markers into clinical care is controversial. We briefly review the...

Determination of the novel melatonin agonist Neu-P11 in plasma samples by liquid chromatography-tandem mass spectrometry.

Melatonin is a major chronobiological regulator involved in circadian phasing, sleep, and numerous other functions. The novel melatonin agonist Neu-P11 is used in treatment of physiological insomnia....

Clinical Trials [ 2 Associated Clinical Trials listed on BioPortfolio]

Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia

Since subjective well-being and quality of life (QoL) are increasingly being recognized as important treatment outcomes in patients with schizophrenia (Hofer et al., 2004; Becker et al., 2...

ADDICTAO: Psychological and Addictive Profile of Patients With Buerger's Disease

Background: Buerger's disease (thromboangiitis obliterans or TAO) is a rare disease (1/ 10 000) characterized by the development of segmental thrombotic occlusions of the medium and small...

Companies [ 2 Associated Companies listed on BioPortfolio]

Brinks Hofer Gilson & Lione

Brinks Hofer Gilson & Lione was founded in 1917 as the two-man patent law firm of Wilkinson & Huxley. Today Brinks has approximately 150 attorneys, supported by a full complement of scientific advisor...

Gilson, Inc.

The Gilson legacy began in the 1940s, when Dr. Gilson, while a faculty member at the University of Wisconsin Medical School, began to design and develop specialized medical electronics and instruments...

More Information about "Brinks Hofer Gilson & Lione" on BioPortfolio

We have published hundreds of Brinks Hofer Gilson & Lione news stories on BioPortfolio along with dozens of Brinks Hofer Gilson & Lione Clinical Trials and PubMed Articles about Brinks Hofer Gilson & Lione for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Brinks Hofer Gilson & Lione Companies in our database. You can also find out about relevant Brinks Hofer Gilson & Lione Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement